Dolca Thomas serves as Executive at Principia Biopharma Inc., where they oversee executive responsibilities. Since joining the company, Dolca Thomas has executed 10 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 11, 2023 involved selling 13,300 shares valued at $0.
Dolca Thomas currently holds 13,300 shares of Principia Biopharma Inc. (PRNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dolca Thomas has been a net seller of PRNB stock. They have purchased $212.2K and sold $2.7M worth of shares.
Dolca Thomas's most recent insider trade was on Aug 11, 2023, when they sold 13,300 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 3,300 |
| $N/A |
| Discretionary |
| Sep 2, 2022 | KDNY | $6.4K | Purchase | 300 | $21.20 | Discretionary |
| Sep 2, 2022 | KDNY | $205.8K | Purchase | 9,700 | $21.22 | Discretionary |
| Sep 28, 2020 | PRNB | $220.7K | Tender | 2,207 | $100.00 | Discretionary |
| Aug 18, 2020 | PRNB | $1.5M | Sale | 15,000 | $100.00 | Discretionary |
| Aug 18, 2020 | PRNB | $356.6K | Option Exercise | 15,000 | $23.77 | Discretionary |
| Jul 15, 2020 | PRNB | $356.6K | Option Exercise | 15,000 | $23.77 | Discretionary |
| Jul 15, 2020 | PRNB | $1.2M | Sale | 15,000 | $80.07 | Discretionary |
| Dec 19, 2019 | PRNB | $29.7K | Sale | 495 | $60.00 | Discretionary |